2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis

Ross, Douglas S., Burch, Henry B., Cooper, David S., Greenlee, M. Carol, Laurberg, Peter, Maia, Ana Luiza, Rivkees, Scott A., Samuels, Mary +3 more·2016·Thyroid®

Cited by (1,000)

Items 201–300 of 1,000

  1. Thyroid vascularization is an important ultrasonographic parameter in untreated Graves’ disease patients
    Roberto Vita, Flavia Di Bari, Sarah Perelli, Giovanni Capodicasa, Salvatore Benvenga · 2019 · Journal of Clinical & Translational Endocrinology
  2. Patients Treated for Hyperthyroidism Are at Increased Risk of Becoming Obese: Findings from a Large Prospective Secondary Care Cohort
    Barbara Torlińska, Linda Nichols, Mohammed A. Mohammed, Chris McCabe, Kristien Boelaert · 2019 · Thyroid
  3. Prevalence of hyperfunctioning thyroid nodules among those in need of fine needle aspiration cytology according to ATA 2015, EU-TIRADS, and ACR-TIRADS
    Benjamin Noto, Maria Eveslage, Michaela Pixberg · 2020 · European Journal of Nuclear Medicine and Molecular Imaging
  4. Fate of organic pollutants in sewage sludge during thermal treatments: Elimination of PCBs, PAHs, and PPCPs
    Mozhdeh Alipour, Hossein Asadi, Chengrong R. Chen, Ali Asghar Besalatpour · 2022 · Fuel
  5. Diagnostic Values of Free Triiodothyronine and Free Thyroxine and the Ratio of Free Triiodothyronine to Free Thyroxine in Thyrotoxicosis
    Xinxin Chen, Yulin Zhou, Mengxi Zhou, Qinglei Yin, Shu Wang · 2018 · International Journal of Endocrinology
  6. Prevalence of thyroid dysfunction in a Large Southern European Population. Analysis of modulatory factors. The APNA study
    Silvia Santos Palacios, María Llavero-Valero, Antonio Brugos‐Larumbe, Juan José Díez, Francisco Guillén‐Grima, Juan C. Galofré · 2018 · Clinical Endocrinology
  7. Analysis in Choroidal Thickness in Patients with Graves’ Ophthalmopathy Using Spectral-Domain Optical Coherence Tomography
    Nan Yu, Yadi Zhang, Lei Kang, Ying Gao, Junqing Zhang, Yuan Feng Wu · 2018 · Journal of Ophthalmology
  8. Neutropenia in patients with hyperthyroidism: Systematic review and meta‐analysis
    Lorenzo Scappaticcio, Maria Ida Maiorino, Antonietta Maio, Katherine Esposito, Giuseppe Bellastella · 2020 · Clinical Endocrinology
  9. SARS-CoV-2 vaccine-induced subacute thyroiditis
    Krupa R. Patel, Mary Elizabeth Cunnane, Daniel G. Deschler · 2021 · American Journal of Otolaryngology
  10. Functional polymorphisms in pre-miR146a and pre-miR499 are associated with systemic lupus erythematosus but not with rheumatoid arthritis or Graves’ disease in Mexican patients
    Isidro Alemán‐Ávila, Mayra Jiménez-Morales, Olga Beltrán-Ramírez et al. · 2017 · Oncotarget
  11. Risk profile analysis and complications after surgery for autoimmune thyroid disease
    Oliver Thomusch, Carsten Sekulla, Franck Georges Billmann et al. · 2018 · British journal of surgery
  12. Nonthionamide Drugs for the Treatment of Hyperthyroidism: From Present to Future
    Nattakarn Suwansaksri, Lukana Preechasuk, Tada Kunavisarut · 2018 · International Journal of Endocrinology
  13. The timing of parathyroid hormone measurement defines the cut-off values to accurately predict postoperative hypocalcemia: a prospective study
    Eduardo Bardou Yunes Filho, Rafael Vaz Machry, Rodrigo Mesquita, Rafael Selbach Scheffel, Ana Luiza Maia · 2018 · Endocrine
  14. Long-Term Treatment of Hyperthyroidism with Antithyroid Drugs: 35 Years of Personal Clinical Experience
    Fereidoun Azizi · 2020 · Thyroid
  15. The longer the antithyroid drug is used, the lower the relapse rate in Graves’ disease: a retrospective multicenter cohort study in Korea
    So Young Park, Bo Hyun Kim, Mijin Kim, A Ram Hong, Jun Tae Park, Hyunju Park, Min Sun Choi, Tae Hyuk Kim, Sun Wook Kim, Ho‐Cheol Kang et al. · 2021 · Endocrine
  16. Actual Associations between HLA Haplotype and Graves’ Disease Development
    Katarzyna Zawadzka-Starczewska, Bogusław Tymoniuk, Bartłomiej Stasiak · 2022 · Journal of Clinical Medicine
  17. Inheritable and sporadic non-autoimmune hyperthyroidism
    Carolina Ferraz, Ralf Paschke · 2017 · Best Practice & Research Clinical Endocrinology & Metabolism
  18. Association of HLA-C*03:02 with methimazole-induced liver injury in Graves’ disease patients
    Xuesong Li, Shasha Jin, Yujuan Fan, Xiaofang Fan, Zhijia Tang, Weimin Cai, Jialin Yang, Xiaoqiang Xiang · 2019 · Biomedicine & Pharmacotherapy
  19. Diagnostic procedure in suspected Graves’ disease
    Goichot, Bernard, Leenhardt, Laurence, Massart, Catherine, Raverot, Véronique, Tramalloni, Jean, Iraqi, Hinde · 2018 · Annales d Endocrinologie
  20. Thyroid and parathyroid surgeon case volume influences patient outcomes: A systematic review
    Harjot K. Bedi, Nicole Jedrzejko, Anne Nguyen, Sebastian R. Aspinall, Sam M. Wiseman · 2021 · Surgical Oncology
  21. Subacute thyroiditis after SARS-CoV-2 vaccination: a report of two sisters and summary of the literature
    Sofia Chatzi, Athina Karampela, Chara Spiliopoulou · 2021 · HORMONES
  22. ACR Appropriateness Criteria® Thyroid Disease
    Jenny K. Hoang, Jorge Daniel Oldan, Susan J. Mandel, Bruno A. Policeni, Vikas Agarwal, Judah Burns, Julie Bykowski, Harlan Benjamin Harvey, Amy F. Tsang Juliano, Tabassum A. Kennedy et al. · 2019 · Journal of the American College of Radiology
  23. Mental Health Conditions and Hyperthyroidism
    Sarah J Zader, Ernest Williams, Melissa A. Buryk · 2019 · Pediatrics
  24. Physician-Perceived Impact of Thyroid Eye Disease on Patient Quality of Life in the United States
    Yao Wang, Anu Rani Sharma, Lissa Padnick‐Silver · 2020 · Ophthalmology and Therapy
  25. Expert consensus on diagnosis and treatment for elderly with thyroid diseases in China (2021)
    Youshuo Liu, Zhongyan Shan, Endocrine Metabolic Diseases Group of the Chinese Geriatrics Society · 2021 · Aging Medicine
  26. Thyroid functional and molecular imaging
    Luca Giovanella, Anca M. Avram, Petra Petranović Ovčariček, Jérôme Clerc · 2022 · La Presse Médicale
  27. Relationship between gut microbiota and thyroid function: a two-sample Mendelian randomization study
    Liangzhuo Xie, Huaye Zhao, Wei Chen · 2023 · Frontiers in Endocrinology
  28. Rationalizing Thyroid Function Testing: Which TSH Cutoffs Are Optimal for Testing Free T4?
    Henze, Meg, Brown, Suzanne J, Hadlow, Narelle C, Walsh, John P · 2017 · The Journal of Clinical Endocrinology & Metabolism
  29. Thyrotoxic Cardiomyopathy: State of the Art
    Juan Eduardo Quiroz Aldave, María del Carmen Durand‐Vásquez, Carlos Jhonatan Lobato-Jeri, Division of Cardiology, Clínica La Luz, Lima, Perú, Juan Manuel Muñoz Moreno, Diana Carolina Deutz-Gómez Condori, Sofía Pilar Ildefonso-Najarro, Felipe Contreras-Yametti, Francisca Elena Zavaleta‐Gutiérrez, Luis Alberto Concepción Urteaga et al. · 2023 · touchREVIEWS in Endocrinology
  30. Enhancing thyroid disease prediction and comorbidity management through advanced machine learning frameworks
    P. Sanju, Nadeem Ahmed, P. Ramachandran, P. Mohamed Sajid, R. Jayanthi · 2025 · Clinical eHealth
  31. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy
    Sung Hoon Yu, Jun Goo Kang, Chul Sik Kim, Sung‐Hee Ihm, Moon Gi Choi, Hyung Joon Yoo, Seong Jin Lee · 2017 · Thyroid
  32. Issues in amiodarone-induced thyrotoxicosis: Update and review of the literature
    Salwan Maqdasy, Thomas Benichou, Sarah Dallel, Béatrice Roche, Françoise Desbiez, Nathanaëlle Montanier, Marie Batisse‐Lignier, Igor Tauveron · 2018 · Annales d Endocrinologie
  33. Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
    Fereidoun Azizi, Hengameh Abdi, Atieh Amouzegar · 2021 · BMC Endocrine Disorders
  34. Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment
    Brooke T. Johnson, Evan Jameyfield, Vinay Kumar Aakalu · 2020 · Current Opinion in Neurology
  35. A Systematic Review and Meta-Analysis of the Relationship Between the Radiation Absorbed Dose to the Thyroid and Response in Patients Treated with Radioiodine for Graves' Disease
    Jan Taprogge, Paul M. D. Gape, Lily Carnegie-Peake, Iain Murray, Jonathan I. Gear, Francesca A. A. Leek, Steve L. Hyer, Glenn Flux · 2021 · Thyroid
  36. Clinical Review and Update on the Management of Thyroid Storm.
    Reuben De Almeida, Sean Mccalmon, Peminda K. Cabandugama · 2022 · PubMed Central
  37. The management and metabolic characterization: hyperthyroidism and hypothyroidism
    Yangyang Wang, Yanping Sun, Bing‐You Yang, Qiuhong Wang, Haixue Kuang · 2022 · Neuropeptides
  38. Thyroid dysfunction following radiofrequency ablation for benign thyroid nodules: more likely to occur within one-week and in high-risk population
    Wang, Nana, Zheng, Bowen, Wu, Tao, Tan, Lei, Lian, Yufan, Ma, Yanping, Guo, Rui, Xu, Shicheng, Zeng, Longyi, Xu, Wen et al. · 2021 · International Journal of Hyperthermia
  39. Epidemiology, prognosis, and challenges in the management of hyperthyroidism-related atrial fibrillation
    Georgios Kostopoulos, Grigoris Effraimidis · 2024 · European Thyroid Journal
  40. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China
    Jun Jie Yang, Linpeng Yao, Mengjie Dong, Qin Xu, Jun Zhang, Wan-Wen Weng, Feng Chen · 2017 · Thyroid
  41. Aging Is Associated with Low Thyroid State and Organ-Specific Sensitivity to Thyroxine
    Helena Rakov, Meri De Angelis, Kostja Renko, Georg Sebastian Hönes, Denise Zwanziger, Lars Christian Moeller, Karl‐Werner Schramm, Dagmar Führer · 2019 · Thyroid
  42. Antithyroid drugs and birth defects
    Stine Linding Andersen, Stig Andersen · 2020 · Thyroid Research
  43. Short-Term Versus 6-Week Prednisone In The Treatment Of Subacute Thyroiditis: A Randomized Controlled Trial
    Lian Duan, Xiaoli Feng, Rui Zhang, Xiaojuan Tan, Xiaoyan Xiang, Rufei Shen, Hongting Zheng · 2020 · Endocrine Practice
  44. Long‐term efficacy and safety of percutaneous ethanol injection (PEI) in cystic thyroid nodules: A systematic review and meta‐analysis
    Roberto Cesareo, Gaia Tabacco, Anda Mihaela Naciu · 2021 · Clinical Endocrinology
  45. Comprehensive immunophenotypic analysis reveals the pathological involvement of Th17 cells in Graves' disease
    Keiichi Torimoto, Yosuke Okada, Shingo Nakayamada, Satoshi Kubo, Akira Kurozumi, Manabu Narisawa, Yoshiya Tanaka · 2022 · Scientific Reports
  46. Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty
    Reese W. Randle, Maria F. Bates, Kristin L. Long, Susan C. Pitt, David F. Schneider, Rebecca S. Sippel · 2017 · Surgery
  47. American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum
    Tim I.M. Korevaar, Angela M. Leung, Erik K. Alexander, Sofie Bliddal, Kristien Boelaert, Gabriela Brenta, Roger Chou, Rima K. Dhillon‐Smith, Chrysoula Dosiou, Jennifer L. Eaton et al. · 2026 · Thyroid
  48. Treatment of patients with Graves' disease and the appropriate extent of thyroidectomy
    Iuliana Bobanga, Christopher R. McHenry · 2019 · Best Practice & Research Clinical Endocrinology & Metabolism
  49. The Evaluation of Low- and High-Dose Steroid Treatments in Subacute Thyroiditis: A Retrospective Observational Study
    Sema Hepşen, Pınar Akhanlı, Muhammed Erkam Sencar, Hakan Düğer, Davut Sakız, Muhammed Kızılgül, İlknur Öztürk Ünsal, Bekir Uçan, Mustafa Özbek, Erman Çakal · 2020 · Endocrine Practice
  50. Thyroid wars: the rise of central actions
    Valentina Capelli, Carlos Diéguez, Jens Mittag, Miguel López · 2021 · Trends in Endocrinology and Metabolism
  51. SARS-CoV-2 vaccine-associated subacute thyroiditis
    Göknur Yorulmaz, Melisa Şahin Tekin · 2022 · Journal of Endocrinological Investigation
  52. Schilddrüsennotfälle
    Christine Spitzweg, Martín Reincke, Roland Gärtner · 2017 · Der Internist
  53. Trends in prevalence of thyroid dysfunction and its associations with mortality among US participants, 1988-2012.
    Zhang, Xiaowen, Wang, Yong, Wang, Hongwei, Zhang, Xinlin · 2024 · The Journal of Clinical Endocrinology & Metabolism
  54. Teprotumumab for the Treatment of Thyroid Eye Disease
    Shoaib Ugradar, Emil Malkhasyan, Raymond S. Douglas · 2024 · Endocrine Reviews
  55. A retrospective cohort study: Do patients with graves’ disease need to be euthyroid prior to surgery?
    Abrar Al Jassim, Tim Wallace, Sarah Bouhabel · 2018 · Journal of Otolaryngology - Head and Neck Surgery
  56. Effects of Preoperative Iodine Administration on Thyroidectomy for Hyperthyroidism: A Systematic Review and Meta‐analysis
    Chung‐Hsin Tsai, Po‐Sheng Yang, Jie-Jen Lee, Tsang‐Pai Liu, Chi‐Yu Kuo, Shih‐Ping Cheng · 2019 · Otolaryngology
  57. Systemic safety analysis of mycophenolate in Graves’ orbitopathy
    A. C. H. Lee, M. Riedl, Lara Frommer, Tanja Diana, George Jean Kahaly · 2019 · Journal of Endocrinological Investigation
  58. Incidence and prevalence of hyperthyroidism: a population-based study in the Piedmont Region, Italy
    Marina Caputo, Alessandro Pecere, Andrea Sarro, Chiara Mele, Andrealuna Ucciero, Loredana Pagano, Flavia Prodam, Gianluca Aimaretti, Paolo Marzullo, Francesco Barone‐Adesi · 2020 · Endocrine
  59. Management of thyrotoxicosis during pregnancy
    Stine Linding Andersen, Louise Knøsgaard · 2020 · Best Practice & Research Clinical Endocrinology & Metabolism
  60. Thyroid hormone alterations in critically and non-critically ill patients with SARS-CoV-2 infection
    Dimitra Argyro Vassiliadi, Ιoannis Ilias, Maria E. Pratikaki, Edison Jahaj, Alice Georgia Vassiliou, Maria G. Detsika, Kleio Ampelakiotou, Marina Koulenti, Konstantinos N. Manolopoulos, Stamatios Tsipilis et al. · 2021 · Endocrine Connections
  61. Antithyroid Drug Treatment in Graves’ Disease
    Jae Hoon Chung · 2021 · Endocrinology and Metabolism
  62. The Efficacy and Short- and Long-Term Side Effects of Radioactive Iodine Treatment in Pediatric Graves’ Disease: A Systematic Review
    Sarah L. Lutterman, Nitash Zwaveling‐Soonawala, Hein Jan Verberne, Frederik A. Verburg, A S Paul van Trotsenburg, Christiaan F. Mooij · 2021 · European Thyroid Journal
  63. Prenatal Diagnosis of Resistance to Thyroid Hormone and Its Clinical Implications
    Θεοδώρα Παππά, João Anselmo, Sunnee Mamanasiri, Alexandra M. Dumitrescu, Roy E. Weiss, Samuel Refetoff · 2017 · The Journal of Clinical Endocrinology & Metabolism
  64. Exploring Systemic Autoimmunity in Thyroid Disease Subjects
    Thushani Siriwardhane, Karthik Krishna, Vinodh Ranganathan · 2018 · Journal of Immunology Research
  65. The impact of thyroid disorder on cardiovascular disease: Unraveling the connection and implications for patient care
    Nanny Natalia Mulyani Soetedjo, Dessy Agustini, Hikmat Permana · 2024 · IJC Heart & Vasculature
  66. All-cause and cardiovascular mortality risk after surgery versus radioiodine treatment for hyperthyroidism
    P Giesecke, Viveka Frykman, Göran Wallin, Stefan Lönn, Andrea Discacciati, Ove Törring, Mina A. Rosenqvist · 2017 · British journal of surgery
  67. Long-term outcome of thyrotoxicosis in childhood and adolescence in the west of Scotland: the case for long-term antithyroid treatment and the importance of initial counselling
    Mariam Kourime, Sheena McGowan, Mabrouka A. Altowati, S. Faisal Ahmed, Graham A. Stewart, Scott Williamson, Iain Hunter, Malcolm Donaldson · 2017 · Archives of Disease in Childhood
  68. Diagnostic accuracy of a new fluoroenzyme immunoassay for the detection of TSH receptor autoantibodies in Graves’ disease
    Danilo Villalta, Federica D’Aurizio, Mirella Da Re, Debora Ricci, Francesco Latrofa, Renato Tozzoli · 2018 · Autoimmunity Highlights
  69. Utility of multi-parametric quantitative magnetic resonance imaging of the lacrimal gland for diagnosing and staging Graves’ ophthalmopathy
    Dide Wu, Hongzhang Zhu, Shubin Hong et al. · 2021 · European Journal of Radiology
  70. Appropriate duration of antithyroid drug treatment as a predictor for relapse of Graves’ disease: a systematic scoping review
    Fereidoun Azizi, Hengameh Abdi, Ladan Mehran, Atieh Amouzegar · 2022 · Journal of Endocrinological Investigation
  71. Association of Human Leukocyte Antigen Genotypes with Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine-Induced Subacute Thyroiditis
    Süleyman Nahit Şendur, Füsun Özmen, Seda Hanife Oğuz · 2022 · Thyroid
  72. Management of Subacute Thyroiditis – A Systematic Review of Current Treatment Protocols
    Ishita Ray, Brandon Dsouza, Pallab Sarker, Pawan Agarwal · 2022 · International Journal of General Medicine
  73. Free thyroxine measurement in clinical practice: how to optimize indications, analytical procedures, and interpretation criteria while waiting for global standardization
    Federica D’Aurizio, Jürgen Kratzsch, Damien Gruson, Petra Petranović Ovčariček, Luca Giovanella · 2022 · Critical Reviews in Clinical Laboratory Sciences
  74. 2022 Taiwan clinical multicenter expert consensus and recommendations for thyroid radiofrequency ablation
    Wei‐Che Lin, WenChieh Chen, Pei‐Wen Wang, Yi‐Chia Chan, Yen‐Hsiang Chang, Harn-Shen Chen, Szu‐Tah Chen, Wei‐Chih Chen, Kai‐Lun Cheng, Shun‐Yu Chi et al. · 2022 · ULTRASONOGRAPHY
  75. Clinical outcomes 1 year after empiric 131I therapy for hyperthyroid disorders
    Lavinia Vija Racaru, Charlotte Fontan, Mathilde Bauriaud, S. Brillouet, Olivier Caselles, Slimane Zerdoud, Delphine Bastié, Delphine Vallot, Philippe Jean Caron, Manuel Bardiès et al. · 2017 · Nuclear Medicine Communications
  76. Analysis of current thyroid function test ordering practices
    Joseph K. Kluesner, Darrick Beckman, Joshua M. Tate, Alexis Beauvais, Maria I. Kravchenko, Jana Wardian, Sky Denniston Graybill, Jeffrey A. Colburn, Irene Folaron, Mark W. True · 2017 · Journal of Evaluation in Clinical Practice
  77. The Role of Fibrogenesis and Extracellular Matrix Proteins in the Pathogenesis of Graves’ Ophthalmopathy
    Hsun-I Chiu, Shi‐Bei Wu, Chieh‐Chih Tsai · 2024 · International Journal of Molecular Sciences
  78. Survey of Clinical Practice Patterns in the Management of 992 Hyperthyroid Patients in France
    Bernard Goichot, Stephane Bouée, Claire Castello-Bridoux, Philippe Jean Caron · 2017 · European Thyroid Journal
  79. Single-Session High-Intensity Focused Ultrasound Treatment for Persistent or Relapsed Graves Disease: Preliminary Experience in a Prospective Study
    Brian Hung‐Hin Lang, Yu Cho Woo, Ian Y. Wong, Keith Wan-Hang Chiu · 2017 · Radiology
  80. Clinical Diagnostic Evaluation of Thyroid Nodules
    Carolyn Maxwell, Jennifer A. Sipos · 2019 · Endocrinology and Metabolism Clinics of North America
  81. Challenges and perspectives of selenium supplementation in Graves’ disease and orbitopathy
    Tomasz Bednarczuk, Lutz Schomburg · 2019 · HORMONES
  82. Early administration of glucocorticoid for thyroid storm: analysis of a national administrative database
    Atsushi Senda, Akira Endo, Hisateru Tachimori, Kiyohide Fushimi, Yasuhiro Otomo · 2020 · Critical Care
  83. Global FT4 immunoassay standardization: an expert opinion review
    Jüergen Kratzsch, Nikola A. Baumann, Ferruccio Ceriotti, Zhong Xian Lu, Matthias Schott, Antonius Eduard van Herwaarden, José Gilberto H. Vieira, Dusanka Kasapic, Luca Giovanella · 2020 · Clinical Chemistry and Laboratory Medicine (CCLM)
  84. Solubility determination and analysis of methimazole in different solvent systems at T = 278.15–323.15 K
    Chen Chen, Peng Chao Zhou, Rensong Wang, Fu Zhu, Wei Sun, Weiliang Shen, Hanhan Xu, Guoxing Hu, Yonghong Hu, Wenge Yang · 2021 · Journal of Molecular Liquids
  85. Risk Factors for Subacute Thyroiditis Recurrence: A Systematic Review and Meta-Analysis of Cohort Studies
    Jing Zhang, Guoyong Ding, Jingru Li, Xiao Li, Lin Ding, Xiangyun Li, Shuxiang Yang, Fang Tang · 2021 · Frontiers in Endocrinology
  86. Disparities in Thyroid Care
    Debbie Chen, Michael W. Yeh · 2022 · Endocrinology and Metabolism Clinics of North America
  87. Distinct Clinical Features of Post-COVID-19 Vaccination Early-onset Graves’ Disease
    Luigi di Filippo, Laura Castellino, Agnese Allora, Stefano Frara, Roberto Lanzi, Francesca Perticone, Fanny Valsecchi, Alberto Vassallo, Raffaele Giubbini, Clifford james Rosen et al. · 2022 · The Journal of Clinical Endocrinology & Metabolism
  88. Outcomes of Patients With Graves Disease 25 Years After Initiating Antithyroid Drug Therapy
    Ann‐Elin Meling Stokland, Marie Austdal, Bjørn Gunnar Nedrebø, Siri Carlsen, Hanne Brit Hetland, Lars Breivik, Hans Olav Ueland, Torquil Watt, Per Karkov Cramon, Kristian Løvås et al. · 2023 · The Journal of Clinical Endocrinology & Metabolism
  89. The long-term outcomes of thyroid function after subtotal thyroidectomy for Graves' hyperthyroidism
    Yann‐Sheng Lin, Jen‐Der Lin, Chih-Chieh Hsu, Ming‐Chin Yu · 2017 · Journal of Surgical Research
  90. Alterations of Global DNA Methylation and DNA Methyltransferase Expression in T and B Lymphocytes from Patients with Newly Diagnosed Autoimmune Thyroid Diseases After Treatment: A Follow-Up Study
    Qingling Guo, Dan Wu, Huixin Yu · 2018 · Thyroid
  91. Thyroid Incidentalomas Detected on 18 F-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography: Malignant Risk Stratification and Management Plan
    Sae Rom Chung, Young Jun Choi, Chong Hyun Suh et al. · 2018 · Thyroid
  92. Increased risk of postoperative complications after total thyroidectomy with Graves' disease
    Hyungju Kwon, Jong‐kyu Kim, Woosung Lim, Byung‐In Moon, Nam Sun Paik · 2018 · Head & Neck
  93. The role of therapeutic plasmapheresis in patients with hyperthyroidism
    Özden Özdemir Başer, Zeynep Çetin, Merve Çatak, Derya Köseoğlu, Dilek Sensoz Berker · 2020 · Transfusion and Apheresis Science
  94. Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism
    Ali Abbara, Sophie A. Clarke, Rosalind Brewster, Alexia Simonnard, Pei Chia Eng, Maria Phylactou, Deborah Papadopoulou, Chioma N. Izzi‐Engbeaya, Amir H. Sam, Florian Wernig et al. · 2020 · Frontiers in Endocrinology
  95. Predictive factors for early hypothyroidism following the radioactive iodine therapy in Graves’ disease patients
    Rui-Ting Hu, Deshan Liu, Bin Li · 2020 · BMC Endocrine Disorders
  96. Prognosis of papillary thyroid cancer in patients with Graves’ disease: a propensity score-matched analysis
    Hyungju Kwon, Byung-In Moon · 2020 · World Journal of Surgical Oncology
  97. Towards a goal-oriented methodology for clinical-guideline-based management recommendations for patients with multimorbidity: GoCom and its preliminary evaluation
    Alexandra Kogan, Mor Peleg B, Samson W. Tu, Raviv Allon, Natanel Khaitov, Irit Hochberg · 2020 · Journal of Biomedical Informatics
  98. Thyroidectomy in Pediatric Patients with Graves’ Disease: A Systematic Review of Postoperative Morbidity
    Annabel S. Zaat, Joep P. M. Derikx, Nitash Zwaveling‐Soonawala, A S Paul van Trotsenburg, Christiaan F. Mooij · 2020 · European Thyroid Journal
  99. Molecular Imaging for Thyrotoxicosis and Thyroid Nodules
    Luca Giovanella, Anca M. Avram, Jérôme Clerc · 2021 · Journal of Nuclear Medicine
  100. Does Radioactive Iodine Therapy for Hyperthyroidism Cause Cancer?
    Brian W. Kim · 2021 · The Journal of Clinical Endocrinology & Metabolism